Previous studies showed that miR‐223 could promote inflammatory damage in the CNS system by targeting ATG16L1,27 and that ATG16L1 has been shown to inhibit lung injury caused by infection by regulating the expression of IL‐22 or IFN.28 This evidence concerns the gene IL22 and infection.